Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Over-The-Counter Viagra Could Be Coming to a Pharmacy Near You

XTALKS VITALS NEWS

Viagra

Viagra, marketed by Pfizer, has been a blockbuster drug since its launch 20 years ago.

Share this!

March 31, 2017 | by Sarah Hand, M.Sc.

The British Medicines and Healthcare Products Regulatory Agency (MHRA) is looking at making Viagra (sildenafil) available as an over-the-counter (OTC) medication in the UK. While the erectile dysfunction drug is currently only available by prescription, the agency is seeking public comment on the possible change until April 18.

Viagra, marketed by Pfizer, has been a blockbuster drug since its launch 20 years ago. In 2012, sales of the erectile dysfunction drug reached $2 billion, however the launch of generic versions has eroded sales by about $400 million.

In 2013, global pharmaceutical company Actavis, launched generic versions of Viagra in Europe. In the US, patients won’t be able to get a generic form of the drug until late 2017.



One of the drivers behind making Viagra an OTC medication is to discourage people from ordering the drug through online pharmacies, which may or may not be licensed. Since its launch, Viagra has been vulnerable to drug counterfeiters who sell fake versions to men who might be too embarrassed to get a prescription for the drug from their doctors.

“The availability of pharmacist-supplied, non-prescription sildenafil could offer men a new and additional way to access a legitimate, long established, and well-studied treatment for erectile dysfunction,” said Dr. Berkeley Phillips, UK Medical Director, Pfizer. “This could have further benefits as the condition may be an early warning sign of a more serious underlying condition, such as heart disease, which may otherwise go undetected.”

Pfizer pushed to get Viagra reclassified as an OTC drug back in 2008, however the European Medicines Agency (EMA) denied the request due to concerns about supply. If the British regulatory agency approves the decision to offer OTC Viagra in pharmacies, Pfizer will likely continue to provide a branded version by prescription.

“Pharmacy availability of sildenafil tablets would be of value to men who suffer from erectile dysfunction,” said the MHRA document. “Patients can be assessed for suitability by a pharmacist and made aware of the risks, situations where supply is not appropriate and potential interactions with other drugs. The risks of indirect danger arising from missed diagnosis of underlying disease is minimized through the pharmacist using their professional judgement and the checklist to identify patients for whom the product is not suitable, and referring these patients to a doctor.”


Keywords:  OTC Drug, Blockbuster Drug, Prescription


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Canadian Regulator Recalls Pie Shells Over E. Coli Contaminated Flour

April 28, 2017 - Multiple brands of pie and tart shells are being recalled in Canada after the flour used to manufacture them was linked to 28 cases of illness due to infection with E. coli O121.

Featured In: Food News


FDA Sends Warning Letters to Manufacturers of Fake Cancer Drugs

April 27, 2017 - The FDA is cracking down on the sale of illegal cancer drugs by sending warning letters to 14 US companies selling the unapproved products.

Featured In: Life Science News, Drug Safety News


Womb-Like Device Could Increase Survival of Premature Babies

April 27, 2017 - Researchers at the Children's Hospital of Philadelphia (CHOP) have developed a womb-like device which mimics the environmental conditions found inside the uterus.

Featured In: Life Science News, Medical Device News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation

REGISTER FOR THESE WEBINARS

Technology Solutions for Late Phase Research: Optimising Real World Data Assets


Serialization for Late Starters – With Live Industry Research Results


Clinical Not All Antioxidants Are Created Equal: Astaxanthin, The Antioxidant Powerhouse


The New Gold Standards of IRT Delivery for Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.